Ikeda Masayuki 池田正行

… Alternative Names

IKEDA Masayuki 池田正行

Less

Researcher Number	10242215
Other IDs
External Links
Affiliation (based on the past Project Information) *help	2021 – 2023: 香川大学, 医学部, 客員研究員 2015 – 2019: 香川大学, 医学部, 客員研究員 2013 – 2015: 香川大学, 医学部, 研究員 2013: 香川大学, 医学部, 客員研究員 2011 – 2012: 長崎大学, 医歯(薬)学総合研究科, 教授 2010 – 2011: 長崎大学, 医歯薬学総合研究科, 教授 2009: 長崎大学, 医歯(薬)学総合研究科, 教授
Review Section/Research Field	Principal Investigator Medical sociology / Basic Section 58010:Medical management and medical sociology-related Except Principal Investigator Medical sociology / New fields of law
Keywords	Principal Investigator 医薬品評価学 / レギュラトリー・サイエンス / 医薬品情報 / 国際比較 / 国際比較研究 / 承認審査 / レギュラトリーサイエンス / ドラッグ・ラグ / 添付文書 / テキストマイニング … More / 新型コロナウイルス感染症 / ワクチン / モニタリング / 医師主導治験 / 人種差 / 生活習慣病 / 効能効果 / 市販後調査 / 高齢化 / 市販後安全性 / 高齢者 / バイオマーカー / 分子標的薬 / 個別化医療医薬品 / 必須医薬品 / 文書解析 / 後発品 / 自然言語処理 / 医薬品情報提供 / データマイニング / 新薬承認審査 / 連合王国 / アメリカ合衆国 / 国際情報交換 / リスクコミュニケーション / ナレッジベース / 適応外使用 / 個別化医療 / 臨床開発 / 臨床試験 … More Except Principal Investigator CBRN対策 / コンパニオン診断 / コンペンディウム / 公知申請 / 適応外使用 / レギュラトリーサイエンス / 顧みられぬ疾病治療薬 / 臨床デザイン / レギュラトリー・サイエンス / 治験と臨床研究の制度的一元化 / リサーチ・ツール特許 / 新薬開発の価格インセンティブ / ヘルステクノロジーアセスメント(HTA) / 薬剤の適正使用 / ドラッグ・ラグ / 研究者主導臨床試験 / 薬剤疫学 / 特許存続期間延長制度 Less

Factors Affecting Regulatory Decisions: Analysis of the Causes of Differences in Drug Indications between CountriesPrincipal Investigator
- Principal Investigator
  
  Ikeda Masayuki
- Project Period (FY)
  2021 – 2023
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 58010:Medical management and medical sociology-related
- Research Institution
  Kagawa University
Drug information and prescription for older adultsPrincipal Investigator
- Principal Investigator
  
  Ikeda Masayuki
- Project Period (FY)
  2017 – 2019
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Medical sociology
- Research Institution
  Kagawa University
How to develop a good patient information leaflet of a medicinePrincipal Investigator
- Principal Investigator
  
  Ikeda Masayuki
- Project Period (FY)
  2014 – 2016
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Medical sociology
- Research Institution
  Kagawa University
Assessment of regulatory efforts to facilitate the approval of off-label drugs
- Principal Investigator
  
  SHIMAZAWA Rumiko
- Project Period (FY)
  2012 – 2015
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Medical sociology
- Research Institution
  Tokai University
  Osaka University
  Kyushu University
  Nagasaki University
Regulatory science research on drug develpment, review, and post-marketing regulationPrincipal Investigator
- Principal Investigator
  
  IKEDA MASAYUKI
- Project Period (FY)
  2011 – 2013
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Medical sociology
- Research Institution
  Kagawa University
  Nagasaki University
Innovation Incentives for New Drug Development and the Enhancement of Safety and Effectiveness Criteria
- Principal Investigator
  
  YAMANE Hiroko
- Project Period (FY)
  2009 – 2011
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Research Field
  
  New fields of law
- Research Institution
  Teikyo University
  National Graduate Institute for Policy Studies

All 2023 2022 2021 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010

All Journal Article Presentation Book

[Book] Chapter 9. Clinical Trial Designs for Testing Companion Diagnostics. In: Il-Jin Kim, ed. Companion Diagnostics (CDx) in Precision Medicine.2019
- Author(s)
  Shimazawa R, Ikeda M.
- Total Pages
  270
- Publisher
  Jenny Stanford Publishing
- ISBN
  9780429275906
- Data Source
  KAKENHI-PROJECT-17K08919
[Book] Chapter 19. Regulatory requirements for companion diagnostics -Japan. In: Jan Trost Jorgensen, eds. Companion and Complementary Diagnostics From Biomarker Discovery to Clinical Implementation. 1st ed.2019
- Author(s)
  Shimazawa R, Ikeda M.
- Total Pages
  508
- Publisher
  Academic Press
- ISBN
  9780128135396
- Data Source
  KAKENHI-PROJECT-17K08919
[Journal Article] Errors Identified by Early, Risk-adapted, Triggered On-site Monitoring in Physician-initiated Clinical Trials not for Regulatory Approval in Cardiovascular Diseases2023
- Author(s)
  Ikehara Y, Morimoto T, Ikeda M, Node K, Ueda S
- Journal Title
  
  Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics
  
  Volume: 54 Issue: 1 Pages: 9-16
- DOI
  10.3999/jscpt.54.1_9
- ISSN
  0388-1601, 1882-8272
- Year and Date
  2023-01-31
- Language
  English
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21K10329
[Journal Article] Comparison of the Quality of Phase Ⅲ Non-commercial Clinical Trials in Japan, the United States, and the United Kingdom before the Implementation of the New Japanese Clinical Trials Act2023
- Author(s)
  Yamauchi Y, Miwa Y, Ikeda M, Ueda S
- Journal Title
  
  Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics
  
  Volume: 54 Issue: 3 Pages: 95-101
- DOI
  10.3999/jscpt.54.3_95
- ISSN
  0388-1601, 1882-8272
- Year and Date
  2023-05-31
- Language
  English
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21K10329
[Journal Article] Women with type 2 diabetes and coronary artery disease have a higher risk of heart failure than men, with a significant gender interaction between heart failure risk and risk factor management: a retrospective registry study2022
- Author(s)
  Fujita Y, Morimoto T, Tokushige A, Ikeda M, Shimabukuro M, Node K, Ueda S
- Journal Title
  
  BMJ Open Diabetes Res Care
  
  Volume: 10 Issue: 2 Pages: e002707-e002707
- DOI
  10.1136/bmjdrc-2021-002707
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-21K10329
[Journal Article] Potential adverse events in Japanese women who received tozinameran (BNT162b2, Pfizer-BioNTech)2021
- Author(s)
  Shimazawa R, Ikeda M.
- Journal Title
  
  Journal of Pharmaceutical Policy and Practice
  
  Volume: 14 Issue: 1 Pages: 46-46
- DOI
  10.1186/s40545-021-00326-7
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-20K10388, KAKENHI-PROJECT-21K10329
[Journal Article] Imbalance in glycemic control between the treatment and placebo groups in cardiovascular outcome trials in type 2 diabetes.2019
- Author(s)
  Shimazawa R, Ikeda M.
- Journal Title
  
  J Pharm Policy Pract
  
  Volume: 12 Issue: 1 Pages: 30-30
- DOI
  10.1186/s40545-019-0193-y
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-17K08919
[Journal Article] Challenges to hemoglobin A1c as a therapeutic target for type 2 diabetes mellitus2019
- Author(s)
  Ikeda Masayuki、Shimazawa Rumiko
- Journal Title
  
  Journal of General and Family Medicine
  
  Volume: 20 Issue: 4 Pages: 1-10
- DOI
  10.1002/jgf2.244
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-16K08882, KAKENHI-PROJECT-17K08919
[Journal Article] Natural language processing-based assessment of consistency in summaries of product characteristics of generic antimicrobials2018
- Author(s)
  Shimazawa R, Kano Y, Ikeda M
- Journal Title
  
  Pharmacol Res Perspect
  
  Volume: 6 Issue: 6
- DOI
  10.1002/prp2.435
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-17K08919, KAKENHI-PROJECT-16K08882
[Journal Article] Pharmacogenomic biomarkers on drug labels: interpretation of United States and Japanese labels based on Pharmacogenetics Knowledgebase2018
- Author(s)
  Shimazawa R., Ikeda M.
- Journal Title
  
  Journal of Clinical Pharmacy and Therapeutics
  
  Volume: 印刷中 Issue: 4 Pages: 500-506
- DOI
  10.1111/jcpt.12692
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-16K08882, KAKENHI-PROJECT-17K08919
[Journal Article] Impact of Risk-Benefit Perception and Trust on Medical Technology Acceptance in Relation to Drug and Device Lag A Tripartite Cross-Sectional Survey2017
- Author(s)
  Todaka K, Kishimoto J, Ikeda M, Ikeda K, Yamamoto H.
- Journal Title
  
  Ther Innov Regul Sci
  
  Volume: － Issue: 5 Pages: 629-640
- DOI
  10.1177/2168479017739267
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-17K08919
[Journal Article] Approval status and evidence for WHO essential medicines for children in the United States, United Kingdom, and Japan: a cross-sectional study2017
- Author(s)
  Shimazawa R, Ikeda M
- Journal Title
  
  Journal of Pharmaceutical Policy and Practice
  
  Volume: 10 Issue: 1 Pages: 4-4
- DOI
  10.1186/s40545-016-0094-2
- Peer Reviewed / Acknowledgement Compliant / Open Access
- Data Source
  KAKENHI-PROJECT-26460604, KAKENHI-PROJECT-16K08882, KAKENHI-PROJECT-17K08919
[Journal Article] Drug-diagnostic co-development: challenges and issues2016
- Author(s)
  Shimazawa R, Ikeda M
- Journal Title
  
  Expert Review of Molecular Diagnostics
  
  Volume: 16 Issue: 2 Pages: 187-204
- DOI
  10.1586/14737159.2016.1132163
- Peer Reviewed / Acknowledgement Compliant
- Data Source
  KAKENHI-PROJECT-26460604, KAKENHI-PROJECT-24590619
[Journal Article] Overcoming regulatory challenges in the development of companion diagnostics for monitoring and safety2016
- Author(s)
  Shimazawa R, Ikeda M
- Journal Title
  
  Personalized Medicine
  
  Volume: 13 Issue: 2 Pages: 155-67
- DOI
  10.2217/pme.15.51
- Peer Reviewed / Acknowledgement Compliant
- Data Source
  KAKENHI-PROJECT-26460604, KAKENHI-PROJECT-24590619
[Journal Article] International differences in companion diagnostic approvals: How are we able to manage the differences?2015
- Author(s)
  Shimazawa R, Ikeda M.
- Journal Title
  
  Expert Review of Molecular Diagnostics
  
  Volume: 15 Issue: 2 Pages: 157-159
- DOI
  10.1586/14737159.2015.969243
- Peer Reviewed / Acknowledgement Compliant / Open Access
- Data Source
  KAKENHI-PROJECT-24590619, KAKENHI-PROJECT-26460604
[Journal Article] Development of drug-approval regulations to medical countermeasures against chemical, biological, radiological, or nuclear agents in Japan2015
- Author(s)
  Shimazawa R, Ikeda M
- Journal Title
  
  Health Security
  
  Volume: 未定 Issue: 2 Pages: 130-138
- DOI
  10.1089/hs.2014.0068
- Peer Reviewed / Acknowledgement Compliant / Open Access
- Data Source
  KAKENHI-PROJECT-26460604, KAKENHI-PROJECT-24590619
[Journal Article] Conflicts of interest in psychiatry: strategies to cultivate literacy in daily practice2014
- Author(s)
  Shimazawa R, Ikeda M.
- Journal Title
  
  Psychiatry and Clinical Neurosciences
  
  Volume: 68 Issue: 7 Pages: 489-497
- DOI
  10.1111/pcn.12201
- Peer Reviewed / Acknowledgement Compliant
- Data Source
  KAKENHI-PROJECT-24590619
[Journal Article] Approval gap of pharmacogenomic biomarkers and in vitro companion diagnostics between the United States and Japan.2014
- Author(s)
  Shimazawa R., Ikeda M.
- Journal Title
  
  Journal of Clinical Pharmacy and Therapeutics
  
  Volume: 39 Issue: 2 Pages: 210-214
- DOI
  10.1111/jcpt.12129
- Peer Reviewed / Acknowledgement Compliant
- Data Source
  KAKENHI-PROJECT-24590619
[Journal Article] Approval gap of pharmacogenomic biomarkers and in vitro companion diagnostics between the United States and Japan2014
- Author(s)
  Shimazawa R, Ikeda M
- Journal Title
  
  J Clin Pharm Ther
  
  Volume: 39 Pages: 210-214
- Data Source
  KAKENHI-PROJECT-23590603
[Journal Article] Differences in pharmacogenomic biomarker information in package inserts from the United States, the United Kingdom, and Japan2013
- Author(s)
  Shimazawa R, Ikeda M
- Journal Title
  
  J Clin Pharm Ther
  
  Volume: 38 Pages: 468-475
- Data Source
  KAKENHI-PROJECT-23590603
[Journal Article] Safety information in drug labeling : a comparison of the United States, the United Kingdom, and Japan2013
- Author(s)
  Shimazawa R, Ikeda M
- Journal Title
  
  Pharmacoepidemiol Drug Saf
  
  Volume: 22 Pages: 306-18
- Data Source
  KAKENHI-PROJECT-23590603
[Journal Article] 産業界及びFDAスタッフ向けガイダンス草案，体外コンパニオン診断機器ガイダンス草案2013
- Author(s)
  嶋澤　るみ子，池田正行
- Journal Title
  
  医薬品医療機器レギュラトリーサイエンス
  
  Volume: 43 Pages: 514-519
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23590603
[Journal Article] Differences in pharmacogenomic biomarker information in package inserts from the United States, the United Kingdom, and Japan.2013
- Author(s)
  Shimazawa R., Ikeda M.
- Journal Title
  
  Journal of Clinical Pharmacy and Therapeutics
  
  Volume: 38 Issue: 6 Pages: 468-475
- DOI
  10.1111/jcpt.12089
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-24590619
[Journal Article] Are there any differences in the regulations of personalised medicine among the US, EU, and Japan?2013
- Author(s)
  Shimazawa R., Ikeda M.
- Journal Title
  
  British Journal of Clinical Pharmacology
  
  Volume: 75 Issue: 5 Pages: 1365-1367
- DOI
  10.1111/j.1365-2125.2012.04462.x
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-24590619
[Journal Article] Safety information in drug labeling: a comparison of the USA, the UK, and Japan2013
- Author(s)
  Rumiko Shimazawa and Masayuki Ikeda
- Journal Title
  
  Pharmacoepidemiology and Drug Safety
  
  Volume: 22 Issue: 3 Pages: 306-318
- DOI
  10.1002/pds.3408
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23590603, KAKENHI-PROJECT-24590619
[Journal Article] Delays in psychiatric drug development in Japan2012
- Author(s)
  Shimazawa R., Kusumi I., Ikeda M.
- Journal Title
  
  Journal of Clinical Pharmacy and Therapeutics
  
  Volume: 37 Issue: 3 Pages: 348-351
- DOI
  10.1111/j.1365-2710.2011.01311.x
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-24590619
[Journal Article] 臨床開発と患者選択に関連したゲノム薬理学バイオマーカーに伴う方法論的問題への考察書　草案（1）2012
- Author(s)
  嶋澤　るみ子，池田正行
- Journal Title
  
  医薬品医療機器レギュラトリーサイエンス
  
  Volume: 43 Pages: 1010-1016
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23590603
[Journal Article] Are there any differences in the regulations of personalised medicine among the US, EU, and Japan?2012
- Author(s)
  Shimazawa R, Ikeda M
- Journal Title
  
  Br J Clin Pharmacol
  
  Volume: 75 Pages: 1365-7
- Data Source
  KAKENHI-PROJECT-23590603
[Journal Article] 臨床開発と患者選択に関連したゲノム薬理学バイオマーカーに伴う方法論的問題への考察書　草案（2）2012
- Author(s)
  嶋澤　るみ子，池田正行
- Journal Title
  
  医薬品医療機器レギュラトリーサイエンス
  
  Volume: 43 Pages: 1097-1105
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23590603
[Journal Article] Delays in psychiatric drug development in Japan2012
- Author(s)
  Shimazawa R, Kusumi I, Ikeda M
- Journal Title
  
  J Clin Pharm Ther
  
  Volume: 37 Pages: 348-351
- Data Source
  KAKENHI-PROJECT-23590603
[Journal Article] The vaccine gap between Japan and the UK2012
- Author(s)
  Shimazawa R, Ikeda M
- Journal Title
  
  Health Policy
  
  Volume: 107 Pages: 312-317
- Data Source
  KAKENHI-PROJECT-23590603
[Journal Article] Japanese regulatory system for approval of off-label drug use : Evaluation of safety and effectiveness in literature-based applications2012
- Author(s)
  Shimazawa R, Ikeda M
- Journal Title
  
  Clin Ther
  
  Volume: 34 Pages: 2104-16
- Data Source
  KAKENHI-PROJECT-23590603
[Journal Article] Japanese regulatory system for approval of off-label drug use: Evaluation of safety and effectiveness in literature-based applications2012
- Author(s)
  Shimazawa R, Ikeda M
- Journal Title
  
  Clin Ther
  
  Volume: 34 Issue: 10 Pages: 2104-16
- DOI
  10.1016/j.clinthera.2012.09.004
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23590603, KAKENHI-PROJECT-24590619
[Journal Article] The vaccine gap between Japan and the UK2012
- Author(s)
  Shimazawa R., Ikeda M.
- Journal Title
  
  Health Policy
  
  Volume: 107 Issue: 2-3 Pages: 312-317
- DOI
  10.1016/j.healthpol.2012.05.012
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-24590619
[Journal Article] Japan lags behind the UK in neurological drug approvals2011
- Author(s)
  Shimazawa R, Ikeda M
- Journal Title
  
  Br J Clin Pharmacol
  
  Volume: 71 Pages: 473-475
- NAID
  120006984773
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21330024
[Journal Article] Donepezil Significantly Improves Abilities in Daily Lives of Female Down Syndrome Patients with Severe Cognitive Impairment : A 24-Week Randomized, Double-Blind, Placebo-Controlled Trial2011
- Author(s)
  Kondoh T, Kanno A, Itoh H, Nakashima M, Honda R, Kojima M, Noguchi M, Nakane H, Nozaki H, Sasaki H, Nagai T, Kosaki R, Kakee N, Okuyama T, Fukuda M, Ikeda M, Shibata Y, Moriuchi H.
- Journal Title
  
  Int J Psychiatry Med
  
  Volume: 41 Pages: 71-89
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21330024
[Journal Article] Japan lags behind the UK in neurological drug approvals2011
- Author(s)
  Shimazawa R, Ikeda M
- Journal Title
  
  Br J Clin Pharmacol
  
  Volume: 71 Pages: 473-475
- NAID
  120006984773
- Data Source
  KAKENHI-PROJECT-23590603
[Journal Article] Delays in neurological drug development in Japan2011
- Author(s)
  Shimazawa R, Ikeda M.
- Journal Title
  
  Internal Medicine
  
  Volume: Vol.50 Pages: 1565-1568
- NAID
  130000969349
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21330024
[Journal Article] Donepezil Significantly Improves Abilities in Daily Lives of Female Down Syndrome Patients with Severe Cognitive Impairment : A 24-Week Randomized, Double-Blind, Placebo-Controlled Trial.2011
- Author(s)
  Kondoh T, Kanno A, Itoh H, Nakashima M, Honda R, Kojima M, Noguchi M, Nakane H, Nozaki H, Sasaki H, Nagai T, Kosaki R, Kakee N, Okuyama T, Fukuda M, Ikeda M, Shibata Y, Moriuchi H.
- Journal Title
  
  Int J Psychiatry Med
  
  Volume: 41 Pages: 71-89
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21330024
[Journal Article] Delays in neurological drug development in Japan2011
- Author(s)
  Shimazawa R, Ikeda M
- Journal Title
  
  Intern Med
  
  Volume: 50 Pages: 1565-1568
- NAID
  130000969349
- Data Source
  KAKENHI-PROJECT-23590603
[Journal Article] Medical management of the acute radiation syndrome2011
- Author(s)
  Shimazawa R, Ikeda M
- Journal Title
  
  Annals of Internal Medicine
  
  Volume: 155 Pages: 135-6
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23590603
[Journal Article] Fulminant form of mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes : A diagnostic challenge2011
- Author(s)
  Ikeda M
- Journal Title
  
  J Med Cases
  
  Volume: 2 Pages: 87-90
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21330024
[Journal Article] Drug development against chemical, biological, radiological, or nuclear agents2011
- Author(s)
  Shimazawa R, Ikeda M
- Journal Title
  
  Lancet
  
  Volume: 378 Pages: 486-486
- Data Source
  KAKENHI-PROJECT-23590603
[Journal Article] Fulminant form of mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes : A diagnostic challenge.2011
- Author(s)
  Ikeda M
- Journal Title
  
  J Med Cases
  
  Volume: 2 Pages: 87-90
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21330024
[Journal Article] Drug development against chemical, biological, radiological, or nuclear agents2011
- Author(s)
  Shimazawa R, Ikeda M.
- Journal Title
  
  Lancet
  
  Volume: Vol.378 Pages: 486-486
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21330024
[Journal Article] Medical management of the acute radiation syndrome2011
- Author(s)
  Shimazawa R, Ikeda M.
- Journal Title
  
  Annals of Intern Medicine
  
  Volume: vol.155 Pages: 135-136
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21330024
[Journal Article] Delays in neurological drug development in Japan2011
- Author(s)
  Shimazawa R, Ikeda M
- Journal Title
  
  Internal Medicine
  
  Volume: 50 Pages: 1565-8
- NAID
  130000969349
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23590603
[Journal Article] Medical management of the acute radiation syndrome2011
- Author(s)
  Shimazawa R, Ikeda M
- Journal Title
  
  Ann Intern Med
  
  Volume: 155 Pages: 135-6
- Data Source
  KAKENHI-PROJECT-23590603
[Journal Article] Drug development against chemical, biological, radiological, or nuclear agents2011
- Author(s)
  Shimazawa R, Ikeda M
- Journal Title
  
  Lancet
  
  Volume: Vol.378 Pages: 486-486
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21330024
[Journal Article] 向精神薬適応拡大の現況と今後の課題2010
- Author(s)
  久住一郎, 池田正行, 小山司
- Journal Title
  
  臨床精神薬理
  
  Volume: 13 Pages: 283-288
- Data Source
  KAKENHI-PROJECT-21330024
[Presentation] 神経疾患のドラッグ・ラグ2012
- Author(s)
  池田正行
- Organizer
  第53回日本神経学会学術集会
- Place of Presentation
  東京国際フォーラム（東京）
- Data Source
  KAKENHI-PROJECT-23590603
[Presentation] 分子標的薬の承認審査報告書における審査のポイント抽出とその解析の試み2012
- Author(s)
  小野大樹, 池田正行, 上村幸司, 長井美和, 横井英人
- Organizer
  第32回医療情報学連合大会
- Place of Presentation
  新潟コンベンションセンター（新潟市）
- Data Source
  KAKENHI-PROJECT-23590603
[Presentation] コンパニオン診断薬の承認審査に関するナレッジベース構築に向けたテキストマイニング技術活用の検討2011
- Author(s)
  小野大樹, 尾崎哲夫, 池田正行, 横井英人
- Organizer
  医療情報学連合大会
- Place of Presentation
  鹿児島市
- Data Source
  KAKENHI-PROJECT-23590603

1. SHIMAZAWA Rumiko (00411083)

# of Collaborated Projects: 5 results

# of Collaborated Products: 36 results
2. YAMANE Hiroko (70200772)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
3. KAWAKAMI Koji (70422318)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
4. NAGANO Hiroshi (80463967)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
5. TANAKA Koichiro (10512353)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
6. MOROOKA Kenichi (00586406)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
7. ISHIMARU Shohei (10612715)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
8. TODAKA Kouji (40398061)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
9. YOKOI Hideto (50403788)

# of Collaborated Projects: 1 results

# of Collaborated Products: 2 results
10. 狩野芳伸 (20506729)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results

Ikeda Masayuki 池田 正行

IKEDA Masayuki 池田 正行

Research Projects

Research Products

Co-Researchers

Factors Affecting Regulatory Decisions: Analysis of the Causes of Differences in Drug Indications between CountriesPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Drug information and prescription for older adultsPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

How to develop a good patient information leaflet of a medicinePrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Assessment of regulatory efforts to facilitate the approval of off-label drugs

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Regulatory science research on drug develpment, review, and post-marketing regulationPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Innovation Incentives for New Drug Development and the Enhancement of Safety and Effectiveness Criteria

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Book] Chapter 9. Clinical Trial Designs for Testing Companion Diagnostics. In: Il-Jin Kim, ed. Companion Diagnostics (CDx) in Precision Medicine.2019

Author(s)

Total Pages

Publisher

ISBN

Data Source

[Book] Chapter 19. Regulatory requirements for companion diagnostics -Japan. In: Jan Trost Jorgensen, eds. Companion and Complementary Diagnostics From Biomarker Discovery to Clinical Implementation. 1st ed.2019

Author(s)

Total Pages

Publisher

ISBN

Data Source

[Journal Article] Errors Identified by Early, Risk-adapted, Triggered On-site Monitoring in Physician-initiated Clinical Trials not for Regulatory Approval in Cardiovascular Diseases2023

Author(s)

Journal Title

DOI

ISSN

Year and Date

Language

Data Source

[Journal Article] Comparison of the Quality of Phase Ⅲ Non-commercial Clinical Trials in Japan, the United States, and the United Kingdom before the Implementation of the New Japanese Clinical Trials Act2023

Author(s)

Journal Title

DOI

ISSN

Year and Date

Language

Data Source

[Journal Article] Women with type 2 diabetes and coronary artery disease have a higher risk of heart failure than men, with a significant gender interaction between heart failure risk and risk factor management: a retrospective registry study2022

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Potential adverse events in Japanese women who received tozinameran (BNT162b2, Pfizer-BioNTech)2021

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Imbalance in glycemic control between the treatment and placebo groups in cardiovascular outcome trials in type 2 diabetes.2019

Ikeda Masayuki 池田正行

IKEDA Masayuki 池田正行